key: cord-0902065-32jbsokt
authors: Liu, Lihong; Wang, Pengfei; Nair, Manoj S.; Yu, Jian; Rapp, Micah; Wang, Qian; Luo, Yang; Chan, Jasper F-W.; Sahi, Vincent; Figueroa, Amir; Guo, Xinzheng V.; Cerutti, Gabriele; Bimela, Jude; Gorman, Jason; Zhou, Tongqing; Chen, Zhiwei; Yuen, Kwok-Yung; Kwong, Peter D.; Sodroski, Joseph G.; Yin, Michael T.; Sheng, Zizhang; Huang, Yaoxing; Shapiro, Lawrence; Ho, David D.
title: Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
date: 2020-07-16
journal: bioRxiv
DOI: 10.1101/2020.06.17.153486
sha: 2efce40bd2158881586f87f92755dfa7bdd25088
doc_id: 902065
cord_uid: 32jbsokt

The SARS-CoV-2 pandemic rages on with devasting consequences on human lives and the global economy1,2. The discovery and development of virus-neutralizing monoclonal antibodies could be one approach to treat or prevent infection by this novel coronavirus. Here we report the isolation of 61 SARS-CoV-2-neutralizing monoclonal antibodies from 5 infected patients hospitalized with severe disease. Among these are 19 antibodies that potently neutralized the authentic SARS-CoV-2 in vitro, 9 of which exhibited exquisite potency, with 50% virus-inhibitory concentrations of 0.7 to 9 ng/mL. Epitope mapping showed this collection of 19 antibodies to be about equally divided between those directed to the receptor-binding domain (RBD) and those to the N-terminal domain (NTD), indicating that both of these regions at the top of the viral spike are immunogenic. In addition, two other powerful neutralizing antibodies recognized quaternary epitopes that are overlapping with the domains at the top of the spike. Cryo-electron microscopy reconstructions of one antibody targeting RBD, a second targeting NTD, and a third bridging two separate RBDs revealed recognition of the closed, “all RBD-down” conformation of the spike. Several of these monoclonal antibodies are promising candidates for clinical development as potential therapeutic and/or prophylactic agents against SARS-CoV-2.

One additional supernatant was initially missed in the pseudovirus screen (Patient 1 in Extended 122 Data Fig. 3 ) but was later found to be a potent neutralizing mAb. Together, these 19 mAbs were 123 purified from transfection supernatants and further characterized for their binding and 124 neutralization properties. As shown in Fig. 2a , all but one (2-43) of the mAbs bound the S trimer 125 by a quantitative ELISA. Nine of the antibodies clearly bound RBD, with little or no binding to 126 NTD. Eight antibodies bound NTD to varying degrees, with no binding to RBD. Two mAbs 127 bound neither RBD nor NTD, and were therefore categorized as "Others". 128 All 19 potent neutralizing mAbs (Fig. 2) were further studied in antibody competition experiments 149 to gain insight into their epitopes. In addition, 12 mAbs that bound the S trimer strongly during 150 the initial supernatant screen were also chosen, including 5 that bound RBD (1-97, 2-26, 4-13, 4-151 24, and 4-29) and 7 that did not bind RBD (1-21, 2-29, 4-15, 4-32, 4-33, 4-41, and 5-45). Four of 152 these mAbs were weak in neutralizing SARS-CoV-2 pseudovirus, and the remaining 8 were non-153 neutralizing (Extended Data Fig. 5 ). First, a total of 16 non-RBD mAbs were evaluated for 154 competition in binding to S trimer by ELISA in a "checkerboard" experiment. The extent of the 155 antibody competition is reflected by the intensity of the heatmap shown in Fig. 3a . There is one 156 large cluster (A) of mAbs that competed with one another, and it partially overlaps a small cluster 157 (B). A third cluster (C) does not overlap at all. Note that all but one of the antibodies in cluster A 158 recognized NTD. Antibody 2-51 is clearly directed to the NTD region even though it could not 159 bind NTD. Moreover, one mAb each from clusters B and C also recognized NTD, thereby 160 indicating that all three clusters are within or near the NTD. One mAb, 1-21, appears to have a 161 unique non-overlapping epitope (epitope region D). 162 163 Second, a similar "checkerboard" competition experiment was carried out by ELISA for 14 of our 164 RBD-directed mAbs plus CR3022 13, 14 . Here, the heatmap shows that there are four epitope 165 clusters that are serially overlapping (Fig. 3a ). There is one large cluster (E) that contains mAbs 166 largely capable of blocking ACE2 binding. Furthermore, 4 antibodies in this cluster lost binding 167 to a mutant RBD (L455R, A475R, G502R) that could no longer bind ACE2 (our unpublished 168 findings). Taken together, these results suggest that most of the mAbs in cluster E are directed to 169 the ACE2-binding interface of RBD. The next cluster (F) connects to both cluster E and cluster 170 G, the location of which is defined by its member CR3022 15 . Lastly, cluster G overlaps another 171 cluster (H), which includes 1-97 that strongly inhibited the binding of 2-30 to the S trimer. This 172 finding suggests that cluster H may be proximal to one edge of cluster E. 173 174 One potent neutralizing mAb, 2-43, did not bind S trimer by ELISA (Fig. 2a) and thus could not 175 be tested in the above competition experiments. However, 2-43 did strongly bind S trimer when 176 expressed on the cell surface as determined by flow cytometry (Extended Data Fig. 6a ), and this 177 binding was competed out by itself but not by RBD, NTD, ACE2, or the soluble S trimer 4 178 (Extended Data Fig. 6b ). NTD-directed mAbs had only a modest effect on its binding to cell-179 surface S trimer, but numerous RBD-directed mAbs in cluster E potently blocked the binding of 180 2-43, demonstrating that this antibody is likely targeting a quaternary epitope on the top of RBD. 181 182 These mapping results could be represented by two sets of Venn diagrams shown in Fig. 3b . In 183 the non-RBD region, the potent neutralizing mAbs reside exclusively in cluster A and bind a patch 184 on the NTD. Weaker neutralizing mAbs recognize a region at the interface between clusters A 185 and B. In the RBD region, the most potent neutralizing mAbs also group together within one 186 cluster (E). Given that all block ACE2 binding, it is likely they recognize the top of RBD and 187 neutralize the virus by competitive inhibition of receptor binding. Cluster G contains CR3022, a 188 mAb known to be directed to an epitope on a cryptic site on the side of RBD when it is in the "up" 189 position 15 . Cluster F is therefore likely situated between the top and this "cryptic" site. The Venn diagram also suggests that cluster H may occupy a different side surface of RBD, perhaps in the 191 region recognized by S309, a mAb isolated from a SARS-CoV-1 patient 8 . 192 193

We produced cryo-EM reconstructions of Fabs from three mAbs in complex with the S trimer 4 . 195 First, single-particle analysis of the complex with 2-4 Fab (RBD-directed) yielded maps of high 196 quality ( Fig. 4a ; Extended Data Table 3 ; Extended Data Fig. 7) , with the most abundant particle 197 class representing a 3-Fab-per-trimer complex, refined to an overall resolution of 3.2 Å. While 198 density for the constant portion of the Fabs was visible, it was blurred due to molecular motion, 199 and thus only the variable domains were included in the molecular model. Table 3 ; Extended Data Fig. 9 ). Two main particle classes were 209 observed -one for a 3-Fab-bound complex with all RBDs "down" at 3.9 Å resolution (Fig. 4b) , 210 and another a 3-Fab-bound complex with one RBD "up" at 4.0 Å resolution (Extended Data Fig.  211 10). However, molecular motion prevented visualization of the interaction at high resolution. Table 3 ; Extended Data Fig. 11 ) revealed three bound Fabs, each targeting a quaternary epitope 218 on the top of the spike that included elements of the RBDs from two adjacent S1 protomers ( Fig.  219 4c), consistent with the epitope mapping results (Extended Data Fig. 6b and Fig. 3b) , including 220 the lack of binding to isolated RBD (Fig. 2a) . Given these findings, the inability of 2-43 to bind S 221 trimer by ELISA is likely an artifact of the assay format, as this mAb did bind the spike expressed 222 on the cell surface and in the cryo-EM study. 223 224 Armed with these three cryo-EM reconstructions, we used the Venn diagrams from Fig. 3b to map 225 the epitopes of many of our SARS-CoV-2 neutralizing mAbs onto the surface of the spike (Fig.  226 4d). This is obviously a rough approximation since antibody footprints are much larger than the 227 area occupied by the mAb number. However, the spatial relationship of the antibody epitopes 228 should be reasonably represented by Nevertheless, vaccine strategies that do not include NTD will be unable to induce an important 260 class of virus-neutralizing antibodies. 261

The isolation of two mAbs (2-43 and 2-51) directed to epitopes that do not map to RBD and NTD 263 is also unprecedented. Cryo-EM of 2-43 Fab bound to the S trimer has confirmed its epitope as 264 quaternary in nature, crossing from the top of one RBD to the top of another RBD (Fig. 4c) . It 265 will be equally informative to understand the epitope of 2-51. In this study, we also show the first 266 evidence by cryo-EM for a neutralizing mAb (4-8) bound to the NTD of the viral spike ( Fig. 4b) , 267 as well as another high-resolution structure of a mAb (2-4) bound to RBD (Fig. 4a) . 

The mammalian expression vector that encodes the ectodomain of the SARS-CoV-2 S trimer and 387 the vector encoding RBD fused with SD1 at the N-terminus and an HRV-3C protease cleavage 388 site followed by a mFc tag and an 8xHis tag at the C-terminus were kindly provided by Jason 389

McLellan 4 . SARS-CoV-2 NTD (aa1-290) with an HRV-3C protease cleavage site, a mFc tag, and 390 an 8xHis tag at the C-terminus was also cloned into mammalian expression vector pCAGGS. Each 391 expression vector was transiently transfected into Expi293 cells using 1 mg/mL of 392 polyethylenimine (Polysciences). Five days post transfection, the S trimer was purified using 393

Strep-Tactin XT Resin (Zymo Research), and the RBD-mFc and NTD-mFc were purified using 394 protein A agarose (ThermoFisher Scientific). In order to obtain RBD-SD1 and NTD, the mFc and 395 8xHis tags at the C-terminus were removed by HRV-3C protease (Millipore-Sigma) and then 396 purified using Ni-NTA resin (Invitrogen) followed by protein A agarose. antigen-specific cells were identified as follows. Briefly, based on the copy numbers of the 420 hashtags observed, a cell must contain more than 100 copies of the antigen sort-specific hashtag 421 to qualify as an antigen-specific cell. Because hashtags can fall off from cells and bind to cells 422 from a different population in the sample mixture, each cell usually has both sorted and spiked-in-423 specific hashtags. To enrich for true antigen-specific cells, the copy number of the specific hashtag 424 has to be at least 1.5x higher than that of the non-specific hashtag. Low quality cells were 425 identified and removed using the cell-calling algorithm in Cell Ranger. Cells that do not have 426 productive H and L chain pairs were excluded. If a cell contains more than two H or/and L chain 427 transcripts, the transcripts with less than 3 unique molecular identifiers were removed. Cells with 428 identical H and L chain sequences, which may have resulted from mRNA leakage, were merged into one cell. Additional filters were applied to remove low quality cells and/or transcripts in the and 10% bovine calf serum (BCS) (Sigma) in PBS at 37°C for 2 hrs. Afterwards, supernatants 521 from the antibody transfection or purified antibodies were serially diluted using dilution buffer (1% 522 BSA and 20% BCS in PBS), incubated at 37°C for 1 hr. Next, 100 µL of 10,000-fold diluted 523

Peroxidase AffiniPure goat anti-human IgG (H+L) antibody (Jackson ImmunoResearch) were 524 added into each well and incubated for 1 hr at 37°C. The plates were washed between each step 525 with PBST (0.5% Tween-20 in PBS). Finally, the TMB substrate (Sigma) was added and 526 incubated before the reaction was stopped using 1M sulfuric acid. Absorbance was measured at 527 450 nm. 528

For the competition ELISA, purified mAbs were biotin-labeled using One-Step Antibody 530

Biotinylation Kit (Miltenyi Biotec) following manufacturer recommendations and purified using 531 40K MWCO Desalting Column (ThermoFisher Scientific). 50 µL of serially diluted competitor 532 antibodies were added into S trimer-precoated ELISA plates, followed by 50 µL of biotinylated 533 antibodies at a concentration that achieves an OD450 reading of 1.5 in the absence of competitor 534 antibodies. Plates were incubated at 37°C for 1 hr, and 100 µL of 500-fold diluted Avidin-HRP 535 (ThermoFisher Scientific) were added into each well and incubated for another 1 hr at 37°C. The 536 plates were washed by PBST between each of the previous steps. The plates were developed 537 afterwards with TMB and absorbance was read at 450 nm after the reaction was stopped. 538 539 For the ACE2 competition ELISA, 100 ng of ACE2 protein (Abcam) was immobilized on the 540 plates at 4°C overnight. The unbound ACE2 was washed away by PBST and then the plates were 541 blocked. After washing, 100 ng of S trimer in 50 µL of dilution buffer was added into each well, 542 followed by adding another 50 µL of serially diluted competitor antibodies and then incubating 543 the plates at 37°C for 1 hr. The ELISA plates were washed 4 times by PBST and then 100 µL of 544 2000-fold diluted anti-strep-HRP (Millipore Sigma) were added into each well for another 1 hr at 545 37°C. The plates were then washed, developed with TMB, and absorbance was read at 450 nm 546 after the reaction was stopped. 

SARS-CoV-2 S trimer at a final concentration of 2 mg/ml was incubated with 6-fold molar excess 567 per spike monomer of the antibody Fab fragments for 30 minutes in 10 mM sodium acetate pH 568 5.5, 150 mM NaCl, and 0.005% n-Dodecyl-β-D-maltoside (DDM). 2 µL of sample were incubated 569 on C-flat 1.2/1.3 carbon grids for 30 secs and vitrified using a Leica EM GP Plunge Freezer. Data 570 were collected on a Titan Krios electron microscope operating at 300 kV equipped with a Gatan 571 K3 direct detector and energy filter using the Leginon software package 34 . A total electron fluence 572 of 51.3 e/Å 2 was fractionated over 40 frames, with a total exposure time of 2 secs. A magnification 573 of 81,000x resulted in a pixel size of 1.058 Å, and a defocus range of -0.4 to -3.5 µm was used. 574

All processing was done using cryoSPARC v2.14.2 35 . Raw movies were aligned and dose-575 weighted using patch motion correction, and the CTF was estimated using patch CTF estimation. 576

A small subset of approximately 200 micrographs were picked using blob picker, followed by 2D 577 classification and manual curation of particle picks, and used to train a Topaz neural network 36 . 578

This network was then used to pick particles from the remaining micrographs, which were 579 extracted with a box size of 384 pixels. 580 581 For the 2-4 Fab dataset, 2D classification followed by ab initio modelling and 3D heterogeneous 582 refinement revealed 83,927 particles with three 2-4 Fabs bound, one to each RBD. A 583 reconstruction of these particles using Non-Uniform Refinement with imposed C3 symmetry 584 resulted in a 3.6 Å map, as determined by the gold standard FSC. Given the relatively low 585 resolution of the RBD-Fab interface, masked local refinement was used to obtain a 3.5 Å map with 586 significantly improved density. A masked local refinement of the remainder of the S timer resulted 587 in a 3.5 Å reconstruction. These two local refinements were aligned and combined using the vop 588 maximum function in UCSF Chimera 37 . This was repeated for the half maps, which were used, along with the refinement mask from the global Non-Uniform refinement, to calculate the 590 3DFSC 38 and obtain an estimated resolution of 3.2 Å. All maps have been submitted to the EMDB 591 with the ID EMD-22156. 592 593 For the 4-8 Fab dataset, image preprocessing and particle picking was performed as above. 2D 594 classification, ab initio modelling, and 3D heterogeneous classification revealed 47,555 particles 595 with 3 Fabs bound, one to each NTD and with all 3 RBDs in the down conformation. While this 596 particle stack was refined to 3.9 Å using Non-Uniform refinement with imposed C3 symmetry, 597 significant molecular motion prevented the visualization of the Fab epitope at high resolution 598 (EMD-22159). In addition, 105,278 particles were shown to have 3 Fabs bound, but with 1 RBD 599 in the up conformation. These particles were refined to 4.0 Å using Non-Uniform refinement with 600 C1 symmetry (EMD-22158), and suffered from the same conformational flexibility as the all-601 RBD-down particles. This flexibility was visualized using 3D variability analysis in cryoSPARC. 602 603 For the 2-43 Fab dataset, which was collected at an electron fluence of 51.69 e/Å2, image 604 preprocessing was performed as above, and particle picking was performed with blob picker. 2D 605 classification, ab initio modelling, and 3D heterogeneous classification revealed 10,068 particles 606 with 3 Fabs bound, which was refined to 5.8Å resolution (EMD-22157). 607 608 Cryo-EM Model Fitting 609 conducted the pseudovirus neutralization assays and M.S.N. and Y.X. performed infectious SARS-

EMDB-22156 for antibody 2-4, EMDB-22158 and EMDB-22159 for antibody 4-8, and EMDB-643 22275 for antibody 2-43

Next-generation sequencing data of antibody repertoires were processed using Cell ranger

2.25, CLUSTALO1.2.3, and USEARCH v9.2.64. Cryo-EM data was 648 collected using Leginon 3.4.beta. Cryo-EM data was processed using cryoSPARC v2

SONAR: A High-Throughput Pipeline for Inferring Antibody 653 Ontogenies from Longitudinal Sequencing of B Cell Transcripts

Gapped BLAST and PSI-BLAST: a new generation of protein database 656 search programs

IMGT, the international ImMunoGeneTics information system

Accurate Alignment of Very Large Numbers of 660 Sequences. Multiple Sequence Alignment Methods 1079

Search and clustering orders of magnitude faster than BLAST

Gene-Specific Substitution Profiles Describe the Types and Frequencies of 665

Amino Acid Changes during Antibody Somatic Hypermutation

Establishment and validation of a pseudovirus neutralization assay for SARS-668

Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies 670 on virus entry, identification of entry inhibitors, and immune responses to vaccines

Automated molecular microscopy: the new Leginon system

cryoSPARC: algorithms for rapid 675 unsupervised cryo-EM structure determination

Positive-unlabeled convolutional neural networks for particle picking in 678 cryo-electron micrographs

UCSF Chimera--a visualization system for exploratory research and 681 analysis

Addressing preferred specimen orientation in single-particle cryo-EM 683 through tilting

Antibody structure determination using a combination of homology 685 modeling, energy-based refinement, and loop prediction

ISOLDE: a physically realistic environment for model building into low-resolution 688 electron-density maps

Coot: model-building tools for molecular graphics

Recent developments in the PHENIX software for automated 693 crystallographic structure determination

MOLPROBITY: structure 696 validation and all-atom contact analysis for nucleic acids and their complexes

EMRinger: side chain-directed model and map validation for 3D cryo-699 electron microscopy

UCSF ChimeraX: Meeting modern challenges in visualization and 701 analysis

Simulation of the clinical and pathological manifestations of Coronavirus 703 Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease 704 pathogenesis and transmissibility

Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive 706 and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In 707 Vitro and with Clinical Specimens

for providing reagents for generating the SARS-CoV-2 S 711 trimer and RBD-SD1 with mFc tag. We thank W. Chen for assistance with generating the Venn 712 diagrams, and B. DeKosky and X. Wu for helpful input

Tencent 714 Charity Foundation

Electron Microscopy Center located at the New York Structural Biology Center, supported by the 717 NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program

GM129539) and by grants from the Simons Foundation (SF349247) and NY State Assembly. Data 719 analysis was performed at the National Resource for Automated Molecular Microscopy 720 (NRAMM), supported by the NIH National Institute of

Hamster experiments were conducted with support from the Health@InnoHK (Centre for Virology

Innovation and Technology Commission, The Government of the

Author Contributions

was responsible for recruiting patients, obtaining clinical specimens, and 728 summarizing clinical data

cloned, expressed, and purified 731 the mAbs. L.L. and Q.W. performed the epitope mapping and binding experiments. P.W. CoV-2 neutralization assays

were responsible for the hamster experiment. Y.L. helped with project 735 management. T.Z. and P.D.K. provided key reagents for the study, and P.D.K. contributed to the 736 analysis and discussion of the data

Acquiring convalescent specimens to isolate and identify potent monoclonal antibodies against

COVID-19" (AAAS9517) was approved by the Columbia University Institutional Review Board

Informed consent was obtained from all participants or surrogates

Competing Interest Declaration 746 A provisional patent application has been filed for the monoclonal antibodies described in the 747 manuscript

Abbreviation: ARDS, acute respiratory distress syndrome

MV, mechanical ventilation; hsCRP, 752 high sensitivity C-reactive protein, ULN>10 mg/L; ESR, erythrocyte sedimentation rate, 753 ULN=20 mm/hr

Extended Data Table 2 Cryo-EM data collection, refinement, and validation statistics

Extended Data Fig. 1 SARS-CoV-2 S trimer-specific antibody isolation strategy. a, Schema 758 for isolating of S trimer-specific mAbs from memory B cells in the blood of infected patients

Sorting results on the isolation of S trimer-specific memory B cells using flow cytometry

Extended Data Fig. 2 Summary of mAb screening of transfection supernatants. a, Numbers 764 of binding and neutralizing antibodies from patients 1 to 5. b, The best-fit pseudovirus 765 neutralization curves for 130 samples

The 18 transfection supernatants that showed evidently better potency are highlighted in colors, 767 while others with non-neutralizing or weakly neutralizing activities are shown in grey

transcripts for heavy, kappa, and lambda chains respectively), IGHV3-30 (antigen-775 specific n=26 and healthy donor n=1117) and IGKV3-20 genes (antigen-specific n=15 and healthy 776 donor n=4,071) are over-represented in heavy and light chain repertoires respectively (P values 777 are 6.415e-11 and 0.04332 respectively, c2-test with 1 degree of freedom)

The 781 CDRH3 length of antigen-specific antibodies is significantly longer than in healthy donors (two-782 sided Kolmogorov-Smirnov test, p=0.014). e, For both heavy and light chains, the V region 783 nucleotide somatic hypermutation levels are significantly lower than in antibodies of healthy 784 donors (two-sided Kolmogorov-Smirnov test, p< 2.2e-16 for both heavy and light chains). For the 785 boxplots, the middle lines are medians. The lower and upper hinges correspond to the first and 786 third quartiles respectively. The upper whisker extends to values no larger than 1.5*IQR (the inter-787 quartile range or distance between the first and third quartiles) from the hinge

Extended Data Fig. 4 Correlation of neutralizing antibody titers of the top 19 mAbs in the 792 live SARS-CoV-2 assay versus the pseudovirus assay. Green circles represent RBD-directed 793 antibodies; orange circles represent NTD-directed antibodies; and black circles represent 794 antibodies in the "Others" category. The Pearson correlation coefficient (r) and the p value were 795 calculated using GraphPad Prism

Extended Data Fig. 7 Cryo-EM analysis of antibody 2-4 in complex with the S trimer

Representative micrograph and CTF of the micrograph. 8,324 micrographs were collected in total

Representative 2D class averages. c, Resolution of the consensus map with C3 symmetry as 813 calculated by 3DFSC. d, The local resolution of the full map as calculated by cryoSPARC at an 814 FSC cutoff of 0.5. e, Representative density of the Fab 2-4 (blue) and RBD (green) interface, 815 showing interactions of CDR H3 in red

Fab 2-4 binding 817 interface with RBD. VH is shown in blue, VL in light blue, with CDRs H1 in orange, H2 in yellow, 818 H3 in red, L1 in magenta, and L3 in light magenta. g, Positions of antibodies 2-4, S309 8 , and BD-819 23 9 on the trimeric CoV-2 spike. h, Antibody BD-23 9 in complex with S trimer. i, Somatic 820 hypermutations found only in the antibody 2-4 heavy chain

Antigen-specific antibody transcripts were processed using our bioinformatics pipeline SONAR 434 for quality control and annotation 26 . Briefly, V(D)J genes were assigned for each transcript using 435 BLAST 27 with customized parameters against a germline gene database obtained from the 436 international ImMunoGeneTics information system (IMGT) database 26, 28 . Based on BLAST 437 alignments of V and J regions, CDR3 was identified using the conserved second cysteine in the V 438 region and WGXG (H chain) or FGXG (L chain) motifs in the J region (X represents any amino 439 acid). For H chain transcripts, the constant domain 1 (CH1) sequences were used to assign isotype 440 using BLAST with default parameters against a database of human CH1 genes obtained from 441 IMGT. A BLAST E-value threshold of 1E-6 was used to find significant isotype assignments, and 442 the CH1 allele with the lowest E-value was used. Sequences other than the V(D)J region were 443 removed and transcripts containing incomplete V(D)J or/and frame shift were excluded. We then 444 aligned each of the remaining transcripts to the assigned germline V gene using CLUSTALO 29 445 and calculated the somatic hypermutation level. 446

To select representative antibodies for functional characterization, we first clustered all antibodies 448 using USEARCH 30 with the following criteria: identical heavy chain V and J gene assignments, 449 the same length of CDRH3, and CDRH3 identity higher than 0.9. For each cluster, cells with the 450 same light chain V and J gene assignments were grouped into a clone. All clone assignments were 451 manually checked. We then calculated the clonal size for each clone, and one H and L chain pair 452 L chains, 20,889 lambda L chains). The repertoire data from the three healthy donors were 460 combined and annotated using SONAR with the same process as above. Recombinant Indiana VSV (rVSV) expressing SARS-CoV-2 spike was generated as previously 475 described 32,33 . HEK293T cells were grown to 80% confluency before transfection with pCMV3-476 SARS-CoV-2-spike (Sino Biological) using FuGENE 6 (Promega). Cells were cultured overnight 477 at 37°C with 5% CO2. The next day, medium was removed and VSV-G pseudotyped ΔG-478 luciferase (G*ΔG-luciferase, Kerafast) was used to infect the cells in DMEM at a MOI of 3 for 479 1 hr before washing the cells with 1X DPBS three times. DMEM supplemented with 2% fetal 480 bovine serum and 100 I.U./mL of penicillin and 100 µg/mL of streptomycin were added to the 481 inoculated cells, which were cultured overnight as described above. The supernatant was 482 harvested the following day and clarified by centrifugation at 300 g for 10 mins before aliquoting 483 and storing at −80°C. BioLuminate 39 . The RBD was initially modeled using the coordinates from PDB ID 6W41. The 611 remainder of the S timer was modeled using the coordinates from PDB ID 6VSB. These models 612 were docked into the consensus map using Chimera. The model was then fitted interactively using 613 ISOLDE 1.0b5 40 and COOT 0.8.9.2 41 , and using real space refinement in Phenix 1.18 42 . In cases 614 where side chains were not visible in the experimental data, they were truncated to alanine.